[1] |
QU Yiping, HOU Peng.
Genetic characteristics and prognosis of metastatic thyroid cancer in children
[J]. China Oncology, 2022, 32(5): 373-379.
|
[2] |
QI Mengfang, TIAN Tian, HUANG Rui.
Clinicopathological characteristics and 131I treatment of differentiated thyroid carcinoma in children and adolescents of different age groups
[J]. China Oncology, 2022, 32(5): 404-409.
|
[3] |
ZHENG Danping, QIAN Wei, ZHENG Chujie.
A study on T-G-C nanomaterials combined with sonodynamic therapy in the treatment of laryngeal cancer
[J]. China Oncology, 2022, 32(5): 436-444.
|
[4] |
Expert Committee of Nuclear Medicine, Chinese society of Clinical Oncology, Expert Committee of Thyroid Cancer, Chinese society of Clinical Oncology, Committee of Thyroid Disease Society, China International Exchange and Promotive Association for Medical and Health Care, Committee of Thyroid Disease Prevention and Treatment Society, China Population Culture Promotion Association.
Expert consensus on management of differentiated thyroid carcinoma in children and adolescents (2022 edition)
[J]. China Oncology, 2022, 32(5): 451-468.
|
[5] |
LIU Wei , WANG Xiaojiang , ZHANG Jing , ZHU Weifeng , PENG Fengying , WANG Jianchao , XIAO Weijin , HU Dan .
Clinicopathological characteristics and prognostic analysis of medullary thyroid carcinoma in children and adolescents
[J]. China Oncology, 2021, 31(11): 1096-1103.
|
[6] |
WEN Duo, LIU Wanlin, CAO Yiming, QU Ning, ZHU Yongxue.
The expressions of cortactin and N-WASP in thyroid papillary carcinoma and their significance
[J]. China Oncology, 2019, 29(9): 688-692.
|
[7] |
SUI Huimin, LIU Jierui, WANG Tong, ZHU Zhaohui, LIN Yansong.
Clinicopathological risk factors for distant metastasis of differentiated thyroid carcinoma in children and adolescents
[J]. China Oncology, 2019, 29(6): 423-428.
|
[8] |
LU Chenghui, LI Jiao, LIU Xinfeng, WANG Guoqiang, WANG Zenghua, WANG Xufu.
Clinical outcome after 131I treatment in differentiated thyroid cancer with negative stimulated thyroglobulin and lymph node metastasis
[J]. China Oncology, 2019, 29(6): 429-433.
|
[9] |
ZHANG Ling, ZHOU Xiaoyan, CHEN Ying, ZHANG Hao, GAO Lili, WANG Yu, JI Qinghai, PING Bo, ZHU Xiaoli.
Clinical significance of BRAF V600E detection in fine-needle aspiration samples of thyroid nodule
[J]. China Oncology, 2019, 29(3): 178-182.
|
[10] |
LIU Jierui, LIANG Jun, LIN Yansong.
Relationship between preablative stimulated thyroglobulin and the excellent response in differentiated thyroid carcinoma
[J]. China Oncology, 2019, 29(2): 125-130.
|
[11] |
ZHANG Yan , WANG Wendong , LAN Xiabin, CHEN Chao.
Clinical analysis of papillary thyroid carcinoma with concomitant Hashimoto’s thyroiditis
[J]. China Oncology, 2019, 29(12): 948-954.
|
[12] |
HE Muzhen, MA Mingping, LIN Yang, et al.
Diagnostic value of dual-energy CT imaging for cervical lymph nodes metastasis in the patients with papillary thyroid cancer
[J]. China Oncology, 2018, 28(7): 497-504.
|
[13] |
ZHANG Lei, DONG Yunwei, HU Shenbao, et al.
The impact of American Cancer Joint Committee Revised Thyroid Cancer Staging System (8th edition)on staging of papillary thyroid carcinoma
[J]. China Oncology, 2018, 28(7): 491-496.
|
[14] |
ZHANG Teng, HU Houyang, BAI Qinghua, et al.
Effect of lymphocytic thyroiditis on response of differentiated thyroid cancer patients after 131I therapy
[J]. China Oncology, 2018, 28(6): 419-423.
|
[15] |
XUE Fen, LI Duanshu, HU Chaosu, et al.
Application of intensity-modulated radiotherapy in locoregionally advanced and recurrent poorly differentiated thyroid carcinoma
[J]. China Oncology, 2018, 28(3): 216-221.
|